TopCare Allergy Relief Fexofenadine tablets recalled for impurity specification failure
Perrigo Company PLC is recalling TopCare Allergy Relief Fexofenadine Hydrochloride 60mg tablets (12-count bottles, Lot #0LE2178) distributed nationwide due to an out-of-specification impurity result found during stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a specification failure. No illnesses or injuries are reported in the source text, and the hazard is the presence of an unspecified impurity identified during routine stability testing—a quality control matter without reported patient harm.
Plain-English summary
Perrigo Company PLC is recalling TopCare Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine (12-count bottles, NDC 36800-954-53) distributed nationwide in the USA. The recall was initiated because stability testing revealed an out-of-specification result for impurity A, indicating the product does not meet required purity specifications.
The affected product lot is #0LE2178 with an expiration date of 01/31/2022, comprising 26,304 containers. The product was manufactured in the Czech Republic and distributed by Topco Associates LC, Elk Grove Village, IL 60007.
Consumers with this product should stop using it and consult their healthcare provider with any questions. For more information, consumers can contact the manufacturer or the FDA at https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls.
The recalled product
- Product
- TopCare Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 12 count bottle, Distributed Topco Associates LC, Elk Grove Village, IL 60007, Made in the Czech Republic, NDC 36800-954-53 UPC 0 36800 33284 3
- Manufacturer
- Perrigo Company PLC
- Hazard
- impurity
- degradation-product
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 0LE2178
- Exp 01/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27